We are live on ! Find out more
CFO

CVA Family Office Portfolio holdings

AUM $1.1B
1-Year Est. Return 26.6%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
+26.6%
3 Year Est. Return
+71.56%
5 Year Est. Return
+71.4%
10 Year Est. Return
AUM
$556M
AUM Growth
-$4.11M
Cap. Flow
-$9.71M
Cap. Flow %
-1.75%
Top 10 Hldgs %
37.7%
Holding
1,310
New
254
Increased
452
Reduced
205
Closed
34

Sector Composition

Rank Sector Weight
1 Technology 8.51%
2 Financials 3.64%
3 Healthcare 3.05%
4 Consumer Staples 2.37%
5 Industrials 2.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIG icon
1176
Signet Jewelers
SIG
$3.76B
$537 ﹤0.01%
+6
New +$593
GLOB icon
1177
Globant
GLOB
$1.61B
$535 ﹤0.01%
+3
New +$529
MTZ icon
1178
MasTec
MTZ
$21.9B
$535 ﹤0.01%
+5
New +$505
BG icon
1179
Bunge Global
BG
$20.8B
$534 ﹤0.01%
+5
New +$525
ELAN icon
1180
Elanco Animal Health
ELAN
$11.1B
$534 ﹤0.01%
+37
New +$591
PATH icon
1181
UiPath
PATH
$7.8B
$533 ﹤0.01%
+42
New +$726
ZETA icon
1182
Zeta Global
ZETA
$6.69B
$530 ﹤0.01%
+30
New +$440
RMBS icon
1183
Rambus
RMBS
$11B
$529 ﹤0.01%
+9
New +$514
LNW
1184
DELISTED
Light & Wonder
LNW
$524 ﹤0.01%
+5
New +$478
FL
1185
DELISTED
Foot Locker
FL
$523 ﹤0.01%
+21
New +$500
MGEE icon
1186
MGE Energy Inc
MGEE
$3.08B
$523 ﹤0.01%
+7
New +$547
DHT icon
1187
DHT Holdings
DHT
$3.02B
$521 ﹤0.01%
+45
New +$528
RBLX icon
1188
Roblox
RBLX
$27B
$521 ﹤0.01%
+14
New +$498
HOLX
1189
DELISTED
Hologic
HOLX
$520 ﹤0.01%
+7
New +$525
PTCT icon
1190
PTC Therapeutics
PTCT
$6.12B
$520 ﹤0.01%
+17
New +$551
VCYT icon
1191
Veracyte
VCYT
$3.8B
$520 ﹤0.01%
+24
New +$505
POR icon
1192
Portland General Electric
POR
$5.77B
$519 ﹤0.01%
+12
New +$517
CWEN icon
1193
Clearway Energy Class C
CWEN
$6.7B
$518 ﹤0.01%
+21
New +$531
EXEL icon
1194
Exelixis
EXEL
$13.4B
$517 ﹤0.01%
+23
New +$510
NEU icon
1195
NewMarket
NEU
$8.18B
$516 ﹤0.01%
+1
New +$556
BEAM icon
1196
Beam Therapeutics
BEAM
$2.84B
$515 ﹤0.01%
+22
New +$540
UNF icon
1197
Unifirst Corp
UNF
$5.25B
$515 ﹤0.01%
+3
New +$484
SPE
1198
Special Opportunities Fund
SPE
$144M
$510 ﹤0.01%
41
TAP icon
1199
Molson Coors Class B
TAP
$8.09B
$508 ﹤0.01%
10
-125
-93% -$7.23K
EXAS
1200
DELISTED
Exact Sciences
EXAS
$507 ﹤0.01%
+12
New +$660

Similar funds

CVA Family Office's Q2 2024 Portfolio in Review

As of Q2 2024, CVA Family Office held 1,310 positions worth $556M, down 0.73% from $560M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

CVA Family Office's Q2 2024 filing shows 254 new, 452 increased, 205 reduced and 34 closed positions. Its largest new stake was iShares iBonds Dec 2028 Term Corporate ETF: 4,605 shares worth $114K. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $6.48M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.

  • CVA Family Office's largest Q2 2024 buy was iShares iBonds Dec 2028 Term Corporate ETF: 4,605 shares worth $114K.
  • CVA Family Office added most to Schwab US Dividend Equity ETF in Q2 2024, an estimated $1.06M increase.
  • CVA Family Office's biggest Q2 2024 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $6.48M.
  • CVA Family Office fully exited Fathom Digital Manufacturing Corporation in Q2 2024, selling an estimated $508K.
  • CVA Family Office's ten largest holdings make up 38% of its $556M portfolio in Q2 2024.
  • CVA Family Office opened 254 new positions and closed 34 in Q2 2024.
  • CVA Family Office's portfolio value fell 0.73% quarter-over-quarter to $556M.

Based on CVA Family Office's 13F filing for Q2 2024, filed 10 Jul 2024.